ClinicalTrials.Veeva

Menu

Cytokine Response in Septic Shock

U

University of Manitoba

Status

Unknown

Conditions

Septic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT01770457
B2009:130

Details and patient eligibility

About

This study is designed to examine the early sequential cytokine responses during antibiotic therapy and resuscitation of septic shock in relation to clinical manifestations of disease.

The specific objective is to obtain sequential serum samples from patients with septic shock, examine a broad range of cytokine responses (TNF, IL-1, IL-6, MIF, LIF, HMGB1, etc) in a rigorous manner and correlate these responses to administration of antibiotics, resuscitative efforts and physiologic responses to illness (temp, HR, blood pressure, WBC, etc).

Full description

Patients must be on vasopressors Patients cannot be on pressors for > 24 hrs prior to consent

Enrollment

325 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult ICU patients: . 18 years admitted with septic shock
  • Receiving Vasopressors < 24 hrs

Exclusion criteria

  • Consent refused by patient or SDM
  • Received Vasopressors > 24hrs

Trial contacts and locations

1

Loading...

Central trial contact

Anand Kumar, MD; Wendy Janz, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems